Phase I dose‐escalation trial of Sym004, an anti‐EGFR antibody mixture, in Japanese patients with advanced solid tumors

Autor Kojima, Takashi, Yamazaki, Kentaro, Kato, Ken, Muro, Kei, Hara, Hiroki, Chin, Keisho, Goddemeier, Thomas, Kuffel, Stefan, Watanabe, Morihiro, Doi, Toshihiko
Vydáno v Cancer Sci (2018)